Safety and efficacy assessment of perixafor in patients with multiple myeloma proven or predicted to be poor mobilizers including assessment of tumor cell mobilization
Tricot G, Cottler-Fox M, Badel K, Calandra G. Safety and efficacy assessment of perixafor in patients with multiple myeloma proven or predicted to be poor mobilizers including assessment of tumor cell mobilization. Haematologica. 2009.